The design of a high quality screening collection is of utmost importance for the early drug discovery process and provides in combination with high quality assay systems the foundation of future discoveries. Herein, we review recent trends and observations to successfully expand the access to bioactive chemical space, including: the feedback from hit assessment interviews of HTS (High-Throughput Screening) campaigns; recent successes with chemogenomics target family approaches; the identification of new relevant target/domain families; DOS (Diversity Oriented Synthesis) and new emerging compound classes; and non-classical approaches, like FBS (Fragment-based screening) and DELs (DNA encoded chemical libraries). The role of in silico libr...
Through the European Lead Factory model, industry-standard high-throughput screening and hit validat...
High throughput screening (HTS) is the dominant force in modern drug discovery. Through the evaluati...
The wealth of bioactivity information now available on low-molecular compounds has enabled a paradig...
High-throughput screening (HTS) is a well established process for lead discovery in Pharma and Biote...
In this case study on an essential instrument of modern drug discovery, we summarize our successful ...
The discovery of small organic molecules capable of binding to specific biological targets represent...
Over the past decade one can observe a scientific revolution taking place resulting in an explosion ...
In lead discovery, libraries of 106 molecules are screened for biological activity. Given the over 1...
Traditionally a pursuit of large pharmaceutical companies, high-throughput screening assays are beco...
This publication describes processes for the selection of chemical compounds for the building of a h...
We introduce a novel strategy to sample the bioactive chemical space, which follows up on hits from ...
High throughput screening (HTS) campaigns, where laboratory automation is used to expose biological ...
Since many projects at pharmaceutical organizations get their start from a high-throughput screening...
The purpose of High Throughput Screening (HTS) in pharmaceutical industry is to identify, as soon as...
The discovery of lead candidate molecules with a therapeutic potential typically involves screening ...
Through the European Lead Factory model, industry-standard high-throughput screening and hit validat...
High throughput screening (HTS) is the dominant force in modern drug discovery. Through the evaluati...
The wealth of bioactivity information now available on low-molecular compounds has enabled a paradig...
High-throughput screening (HTS) is a well established process for lead discovery in Pharma and Biote...
In this case study on an essential instrument of modern drug discovery, we summarize our successful ...
The discovery of small organic molecules capable of binding to specific biological targets represent...
Over the past decade one can observe a scientific revolution taking place resulting in an explosion ...
In lead discovery, libraries of 106 molecules are screened for biological activity. Given the over 1...
Traditionally a pursuit of large pharmaceutical companies, high-throughput screening assays are beco...
This publication describes processes for the selection of chemical compounds for the building of a h...
We introduce a novel strategy to sample the bioactive chemical space, which follows up on hits from ...
High throughput screening (HTS) campaigns, where laboratory automation is used to expose biological ...
Since many projects at pharmaceutical organizations get their start from a high-throughput screening...
The purpose of High Throughput Screening (HTS) in pharmaceutical industry is to identify, as soon as...
The discovery of lead candidate molecules with a therapeutic potential typically involves screening ...
Through the European Lead Factory model, industry-standard high-throughput screening and hit validat...
High throughput screening (HTS) is the dominant force in modern drug discovery. Through the evaluati...
The wealth of bioactivity information now available on low-molecular compounds has enabled a paradig...